Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death.
Marcus E. Peter(Northwestern University), Peter H. Krammer(Slovak Academy of Sciences), Reinhard Schwartz‐Albiez(German Cancer Research Center), Gerhard Moldenhauer(National Center for Tumor Diseases), Matthias Grell(University of Stuttgart), Stefan Hellbardt(German Cancer Research Center), Henning Walczak(CRUK Lung Cancer Centre of Excellence), Michael O. Westendorp(German Cancer Research Center)
PubMed
July 1, 1995
Cited by 92
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
|Genes & Development|2008|2.3k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k